


Healthcare Industry News: HIV/AIDS
News Release - October 31, 2006
Human Genome Sciences Reports Positive Interim Results of Phase 2 Trials of Albuferon(TM) With Ribavirin in Patients With Chronic Hepatitis C
Source: Human Genome Sciences
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
